JUSTTHENEWS (Kevin Killough) - FDA approves pancreatic cancer drug that nearly doubles survival time over chemotherapy
In a key clinical trial, patients receiving the drug achieved a median overall survival of 13.2 months, compared to 6.7 months for patients offered standard chemotherapy.
| Keywords | fdapancreatic-cancercancermedical-breakthroughhealthmedicineclinical-trialspharmaceuticalsdrug-developmentoncologysciencebiotechtreatmentsurvival-ratemedical-innovationpublic-health |